Skip to content

Effectiveness of homoeopathic medicine in the treatment of allergic bronchial asthma.

Effectiveness of individualized homoeopathic medicine as a discrete or as an adjuvant in the treatment of allergic bronchial asthma evaluated by serum Immunoglobulin E levels and spirometry measurements A double arm prospective nonrandomized clinical study - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079493
Enrollment
56
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma Health Condition 2: J459- Other and unspecified asthma

Interventions

Intervention1: individualized homoeopathic treatment along with conventional medicine: homoeopathic treatment along with conventional medicine which patient is already taking on advice of allopathic p

Sponsors

DR Deepshika Sharma self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are having signs and symptoms of allergic asthma. Patients having increased IgE levels. Patients with reduction in FEV1/ FVC ratio. Patients of age 12 to 40 years of age, irrespective of their gender, race, religion and socio- economic status Willingness and ability to comply with scheduled visits, treatment plans and other study procedures. Patient must be capable of giving informed consent. Patient will have option to decide whether to take homoeopathic medicine along with the conventional treatment or to use homoeopathy as discrete mode of treatment. Both the type of patient will be included in the study as two different arm of study

Exclusion criteria

Exclusion criteria: Patients who are diagnosed with an unstable mental or psychiatric illness or other uncontrolled or life-threatening diseases including organ failure that affect the quality of life Patient suffering from status asthmaticus Pregnant or lactating women Patients on substance abuse.

Design outcomes

Primary

MeasureTime frame
Primary outcome: Spirometry at base line and 6 monthsTimepoint: Primary outcome: Spirometry at base line and 6 months

Secondary

MeasureTime frame
IgE levels and ACT SCORE at baseline and 6monthsTimepoint: baseline and 6 months

Countries

India

Contacts

Public ContactDr Deepshika Sharma

National Institute of Homoeopathy

drgautampal@gmail.com9433902556

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026